J Herold1, A Mitrasch2, E Lorenz3, U Lodes4, I Tanev2, R Braun-Dullaeus2, F Meyer3. 1. Klinik für Kardiologie und Angiologie, Medizinische Fakultät der Otto-von-Guericke-Universität, Universitätsklinikum Magdeburg A.ö.R., Leipziger Str. 44, 39120, Magdeburg, Deutschland. joerg_herold@hotmail.com. 2. Klinik für Kardiologie und Angiologie, Medizinische Fakultät der Otto-von-Guericke-Universität, Universitätsklinikum Magdeburg A.ö.R., Leipziger Str. 44, 39120, Magdeburg, Deutschland. 3. Klinik für Allgemein‑, Viszeral‑, Gefäß- und Transplantationschirurgie, Medizinische Fakultät der Otto-von-Guericke-Universität, Universitätsklinikum Magdeburg A.ö.R., Magdeburg, Deutschland. 4. Klinik für Anästhesiologie und Intensivtherapie, Medizinische Fakultät der Otto-von-Guericke-Universität, Universitätsklinikum Magdeburg A.ö.R., Magdeburg, Deutschland.
Abstract
BACKGROUND: Hyperthermia often ends fatally and must therefore be promptly recognized and adequately treated. CASE: A 28-year-old man participated in a long-distance race (3 km) on a hot summer day (28 °C). The runner collapsed, had to vomit but continued the run and reached the finish. Neurologically, the patient presented with intermittent cerebral seizures. External cooling batteries were immediately applied and cold infusions were started. The patient was admitted to the intensive care unit of the university hospital (body temperature 40.2 °C). After a few hours, a manifest disseminated intravascular coagulopathy developed with multiple organ failure. It took 12 l of volume replacement, 8 units of fresh frozen plasma and 2 units of erythrocyte concentrates in the first 12 h to stabilize the patient. Although with the help of forced external cooling and application of cold infusions, the body temperature could be lowered to 38 °C by the next morning, the overall situation of the patient continued to deteriorate. Despite dialysis and massive substitution of coagulation factors, the patient could not be sufficiently stabilized and died of brain edema. CONCLUSION: Not only the old or young children are subject to the potential danger of a fatal heat stroke but also young athletic persons after normal sports activities (3 km run). Cooling must be started immediately and the patient must be hospitalized as a vital emergency. If hemostasis fails due to the heat-related loss of hepatogenic protein synthesis, a viscious circle begins, which, as in the reported case, is irreversible despite maximum therapy and substitution.
BACKGROUND:Hyperthermia often ends fatally and must therefore be promptly recognized and adequately treated. CASE: A 28-year-old man participated in a long-distance race (3 km) on a hot summer day (28 °C). The runner collapsed, had to vomit but continued the run and reached the finish. Neurologically, the patient presented with intermittent cerebral seizures. External cooling batteries were immediately applied and cold infusions were started. The patient was admitted to the intensive care unit of the university hospital (body temperature 40.2 °C). After a few hours, a manifest disseminated intravascular coagulopathy developed with multiple organ failure. It took 12 l of volume replacement, 8 units of fresh frozen plasma and 2 units of erythrocyte concentrates in the first 12 h to stabilize the patient. Although with the help of forced external cooling and application of cold infusions, the body temperature could be lowered to 38 °C by the next morning, the overall situation of the patient continued to deteriorate. Despite dialysis and massive substitution of coagulation factors, the patient could not be sufficiently stabilized and died of brain edema. CONCLUSION: Not only the old or young children are subject to the potential danger of a fatal heat stroke but also young athletic persons after normal sports activities (3 km run). Cooling must be started immediately and the patient must be hospitalized as a vital emergency. If hemostasis fails due to the heat-related loss of hepatogenic protein synthesis, a viscious circle begins, which, as in the reported case, is irreversible despite maximum therapy and substitution.
Authors: Benoît Misset; Bernard De Jonghe; Sylvie Bastuji-Garin; Olivier Gattolliat; Ezzeddine Boughrara; Djillali Annane; Pierre Hausfater; Maïté Garrouste-Orgeas; Jean Carlet Journal: Crit Care Med Date: 2006-04 Impact factor: 7.598
Authors: J E Dematte; K O'Mara; J Buescher; C G Whitney; S Forsythe; T McNamee; R B Adiga; I M Ndukwu Journal: Ann Intern Med Date: 1998-08-01 Impact factor: 25.391
Authors: Gregor Broessner; Ronny Beer; Gerhard Franz; Peter Lackner; Klaus Engelhardt; Christian Brenneis; Bettina Pfausler; Erich Schmutzhard Journal: Crit Care Date: 2005-10-05 Impact factor: 9.097
Authors: Fin Stolze Larsen; Lars Ebbe Schmidt; Christine Bernsmeier; Allan Rasmussen; Helena Isoniemi; Vishal C Patel; Evangelos Triantafyllou; William Bernal; Georg Auzinger; Debbie Shawcross; Martin Eefsen; Peter Nissen Bjerring; Jens Otto Clemmesen; Krister Hockerstedt; Hans-Jørgen Frederiksen; Bent Adel Hansen; Charalambos G Antoniades; Julia Wendon Journal: J Hepatol Date: 2015-08-29 Impact factor: 25.083
Authors: Peter A Falgiano; Trevor L Gillum; Zach J Schall; Harrison R Strag; Matthew R Kuennen Journal: Eur J Appl Physiol Date: 2018-10-01 Impact factor: 3.078
Authors: Simon-Richard Finke; Christoph Jänig; Andreas Deschler; Jan Hanske; Holger Herff; Jochen Hinkelbein; Bernd W Böttiger; W Schmidbauer; Daniel C Schroeder Journal: Notf Rett Med Date: 2021-12-02 Impact factor: 0.892